Carregant...

Quantitative Interrogation of the Human Kinome Perturbed by Two BRAF Inhibitors

Oncogenic BRAF mutations contribute to the development of a number of cancers, and small-molecule BRAF inhibitors have been approved by the Food and Drug Administration (FDA) for anticancer therapy. In this study, we employed two targeted quantitative proteomics approaches for monitoring separately...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Proteome Res
Autors principals: Miao, Weili, Wang, Yinsheng
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6939617/
https://ncbi.nlm.nih.gov/pubmed/30994353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.9b00134
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!